Chang-Lun Shao

29PUBLICATIONS
12CO-AUTHORS
Pharmaceutical delivery technologiesBiologically active moleculesCancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Dec 08, 2025
The Potential, Challenges and New Horizons of Marine Natural Products Against Tuberculosis Infection.

Qun Zhang, Yi-Qian Han, Wei-Feng Xu

|Oct 31, 2025
Discovery of Unprecedented Arylation Coupling Cyclopeptide Inspires Natural Product-like Antitubercular Lead Compounds.

Qun Zhang, Wei-Feng Xu, Qian-Qian Jing

|Oct 29, 2025
Discovery of Oral Natural Benzofuranoid p-Terphenyl Derivative CHNQD-03301 as a Potent Hypoxia-Inducible Factor-1α Signaling Inhibitor for Cancer Therapy.

Cui-Fang Wang, Xiao-Nan Cui, Liu-Xia Lv

|Apr 25, 2025
Marine-Derived Yaequinolone Derivative CHNQD-02792 Suppresses Colorectal Cancer Cell Proliferation and Induces Apoptosis via MAPK Pathway Modulation.

Jia-Qi Kang, Tian-Yi Zhou, Wen-Hui Wang

|Mar 14, 2025
Niacin Ester Derivative of Brefeldin A as a Potential Dual-Target Arf1/BMX Inhibitor for Bladder Cancer.

Jian-Yu Liu, Yi-Jing Song, Peng-Jie Li

|Jan 15, 2025
Screening, Discovery, and Optimization of the Natural Antitubercular Chlorflavonin from a Marine-Derived Fungal Library.

Cui-Fang Wang, Wen-Hui Wang, Ying Xu

Pageof 5

Frequent Collaborators

11 joint publications

Yu-Cheng Gu

9 joint publications

Chang-Yun Wang

3 joint publications

Fei Cao

2 joint publications

Wei-Feng Xu